NO985341L - Formulation comprising microparticles for inhalation - Google Patents

Formulation comprising microparticles for inhalation

Info

Publication number
NO985341L
NO985341L NO985341A NO985341A NO985341L NO 985341 L NO985341 L NO 985341L NO 985341 A NO985341 A NO 985341A NO 985341 A NO985341 A NO 985341A NO 985341 L NO985341 L NO 985341L
Authority
NO
Norway
Prior art keywords
microparticles
inhalation
formulation
hfc
homogeneously
Prior art date
Application number
NO985341A
Other languages
Norwegian (no)
Other versions
NO985341D0 (en
Inventor
Ian Joseph Smith
Cheryl Vanessa Rogerson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO985341L publication Critical patent/NO985341L/en
Publication of NO985341D0 publication Critical patent/NO985341D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Abstract

Mikropartikler med en størrelse opp til 50 pm omfattende et terapeutisk middel og en surfaktant. De kan formuleres homogent med et HFC-drivstoff.Microparticles up to 50 microns in size comprising a therapeutic agent and a surfactant. They can be formulated homogeneously with an HFC fuel.

NO985341A 1996-05-17 1998-11-16 Formulation comprising microparticles for inhalation NO985341D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation
PCT/GB1997/001309 WO1997044012A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation

Publications (2)

Publication Number Publication Date
NO985341L true NO985341L (en) 1998-11-16
NO985341D0 NO985341D0 (en) 1998-11-16

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985341A NO985341D0 (en) 1996-05-17 1998-11-16 Formulation comprising microparticles for inhalation

Country Status (9)

Country Link
JP (1) JP2000512268A (en)
KR (1) KR20000011020A (en)
AR (1) AR007178A1 (en)
AU (1) AU2783897A (en)
CA (1) CA2253478A1 (en)
GB (1) GB9610341D0 (en)
NO (1) NO985341D0 (en)
WO (1) WO1997044012A1 (en)
ZA (1) ZA974328B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
DK1107743T3 (en) * 1998-08-25 2007-10-22 Advanced Inhalation Res Inc Stable, spray-dried protein formulations
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
JP2005514393A (en) 2001-12-19 2005-05-19 ネクター セラピューティクス Supplying aminoglycosides to the lung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
JPH10506406A (en) * 1994-09-29 1998-06-23 アンダリス、リミテッド Spray-dried fine particles as therapeutic vehicles

Also Published As

Publication number Publication date
AR007178A1 (en) 1999-10-13
ZA974328B (en) 1998-05-19
WO1997044012A1 (en) 1997-11-27
KR20000011020A (en) 2000-02-25
NO985341D0 (en) 1998-11-16
AU2783897A (en) 1997-12-09
GB9610341D0 (en) 1996-07-24
JP2000512268A (en) 2000-09-19
CA2253478A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
DK0695172T3 (en) Fast-release solid preparation, its preparation and its use
CA2257810A1 (en) Skin wash composition comprising an .alpha.-hydroxy acid or other acid and a detergent base
EE05210B1 (en) Antidiabetic agent and its use in medicine
ATE269054T1 (en) CONFECT COMPOSITIONS
DK0927367T3 (en) Miniaturized gamma camera device with very high resolution
RS51157B (en) Baff receptor (bcma), an immunoregulatory agent
AU3490300A (en) Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
BR0107869A (en) Electrogenated pharmaceutical compositions
DK1021204T3 (en) Bioadhesive compositions and methods for topical administration of active agents
ZA995601B (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof.
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
MXPA97002401A (en) Antiinflammatory agent for external use.
MY109310A (en) Antimicrobial method and formulation employing type ii endoglucosidase and antimicrobial agent
HK1061362A1 (en) Topical pharmaceutical formulation
DE3485229D1 (en) SHAMPOO PREPARATIONS.
EP0671658B8 (en) Exposure apparatus and reflection type mask to be used in the same
AU2001291800A1 (en) Cleansing/conditioning agents containing matrix particles with a perfume component and a washing-active component
RS20050821A (en) Human serum albumin-free stabilized interferon liquid formulations
NO985341L (en) Formulation comprising microparticles for inhalation
PL362965A1 (en) Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
IL126109A0 (en) Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
WO2002051535A3 (en) Preparation of microparticles having improved flowability
ATE222486T1 (en) INSTANT VESICULAR PRODUCT
DK0841933T3 (en) Bowman-Birk inhibitor preparations for the treatment of inflammatory diseases